🟢 First Tracks Biotherapeutics is trading 8% up in pre-market with no clear catalyst identified

First Tracks Biotherapeutics is trading at $34.00, up 8.31% in pre-market, with no company-specific cause identified.

• Shares closed at $31.39 on October 6.
• No new company announcement explaining the October 7 move appeared on its news-release page; its latest listed release is dated August 26.
• Available reporting described biotech-sector weakness on October 6, while the supplied market snapshot showed a softer pre-market backdrop; neither establishes a catalyst for the gain.